Our oncology-specific Analogue Analyzer includes hundreds of separate products, translating to over 2000 reference analogues, covering multiple indications in multiple markets.
Unlike other analogue tools, it’s unique in that it includes oncology specific variables such as line of therapy, biomarker and patient starts.
Data from patient-based forecasts, offering unmatched transparency.
Based on patient shares with no need to convert volume shares to patients.
Comprehensive Analogue Library which includes patient, efficacy and safety data.
Powerful analysis tools with user-friendly filters to find the precise Analogue you require.
Our expert-developed solution leverages extensive quantitative and qualitative data, seamlessly integrating into your forecasting processes.
See how our flexible, user-friendly tool can build actionable analogues quickly and easily, providing valuable insights with dynamic key outputs
Schedule your demo today!